TherapeuticsMD, Inc. (TXMD): auditor change — TherapeuticsMD dismisses Grant Thornton, engages BPB; prior reports had going concern note

TherapeuticsMD, Inc.

Grant Thornton dismissed as independent auditor on July 7, 2023; Berkowitz Pollack Brant appointed.
GT's reports for FY 2022 and 2021 included an explanatory paragraph on going concern uncertainty.
No disagreements with GT on accounting principles or audit scope; no reportable events occurred.
Audit change resulted from a request for proposal process.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

TherapeuticsMD, Inc. engaged Berkowitz Pollack Brant as its auditor.

Action: engagement
Auditor: Berkowitz Pollack Brant

Exact text from the filing

engaged Berkowitz Pollack Brant ("BPB") as the Company’s independent registered public accounting firm for the 2023 fiscal year

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

TherapeuticsMD, Inc. dismissed Grant Thornton LLP as its auditor.

Action: dismissal
Auditor: Grant Thornton LLP
Successor: Berkowitz Pollack Brant

Exact text from the filing

dismissed Grant Thornton LLP ("GT") as the Company’s independent registered public accounting firm

View on SEC.gov

6 auditor changes filed in the last 30 days. Browse all auditor changes →

TherapeuticsMD, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-184765

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.